Welcome to the InfoSci Platform
R&D Productivity in the Pharmaceutical Industry: Scenario Simulations Using a Bayesian Belief Network

R&D Productivity in the Pharmaceutical Industry: Scenario Simulations Using a Bayesian Belief Network

F.W. (Ward) van Vierssen Trip, Nam C. Nguyen, Ockie J.H. Bosch
Copyright: © 2015 |Volume: 6 |Issue: 1 |Pages: 16
ISSN: 1947-8569|EISSN: 1947-8577|EISBN13: 9781466677531|DOI: 10.4018/ijsds.2015010101
Cite Article Cite Article

MLA

van Vierssen Trip, F.W. (Ward), et al. "R&D Productivity in the Pharmaceutical Industry: Scenario Simulations Using a Bayesian Belief Network." IJSDS vol.6, no.1 2015: pp.1-16. http://doi.org/10.4018/ijsds.2015010101

APA

van Vierssen Trip, F. W., Nguyen, N. C., & Bosch, O. J. (2015). R&D Productivity in the Pharmaceutical Industry: Scenario Simulations Using a Bayesian Belief Network. International Journal of Strategic Decision Sciences (IJSDS), 6(1), 1-16. http://doi.org/10.4018/ijsds.2015010101

Chicago

van Vierssen Trip, F.W. (Ward), Nam C. Nguyen, and Ockie J.H. Bosch. "R&D Productivity in the Pharmaceutical Industry: Scenario Simulations Using a Bayesian Belief Network," International Journal of Strategic Decision Sciences (IJSDS) 6, no.1: 1-16. http://doi.org/10.4018/ijsds.2015010101

Export Reference

Mendeley
Favorite Full-Issue Download

Abstract

The pharmaceutical industry is in a R&D productivity crisis. Rapidly increasing development costs, decreasing profitability of new medical entities and missing breakthrough innovations are negatively affecting the future of the pharmaceutical industry. This complex problem requires a systems thinking approach to find effective solutions. In this study, a general pharmaceutical R&D productivity system has been modeled as a Bayesian Belief Network (BBN). This model is based on a literature review and the mental model of experts in the pharmaceutical field. The model does not only support users to understand the system but is also able to simulate different future scenarios. A blockbuster drug scenario, a generic drug scenario, and a personalized drug scenario has been modeled with three different corresponding outcomes. These simulations enables decision makers to identify the leverage points of the pharmaceutical R&D productivity system. These leverage points could be the foundation of any further strategy development. The R&D productivity system archetype is potentially applicable for other R&D intensive industries.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.